Severe persistent pemphigoid gestationis: Long-term remission with rituximab [1]

British Journal of Dermatology

Volumn 157, Issue 2, 2007, Pages 388-389

  Cianchini, G ^a   Masini, C ^a   Lupi, F ^a   Corona, R ^a   De Pita O ^a   Puddu, P ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; DAPSONE; IMMUNOGLOBULIN; PREDNISONE; RITUXIMAB;

ABSENCE OF SIDE EFFECTS; ADULT; BASAL CELL; CASE REPORT; CELL DEATH; CESAREAN SECTION; DIABETES MELLITUS; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATORY INFILTRATE; LETTER; MOON FACE; OBESITY; OSTEOPOROSIS; PEMPHIGOID GESTATIONIS; PREGNANCY; PRIORITY JOURNAL; PRURITUS; RASH; RELAPSE; REMISSION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; DERMATOLOGIC AGENTS; FEMALE; HUMANS; PEMPHIGOID GESTATIONIS; PREGNANCY; TREATMENT OUTCOME;

EID: 34447542812     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07982.x     Document Type: Letter

References (9)

1. Al-Fouzan AW, Galadari I, Oumeish I, Oumeish OY. Herpes gestationis (pemphigoid gestationis). Clin Dermatol 2006 24 : 109 12.
2. Amato L, Mei S, Gallerani I et al. A case of chronic herpes gestationis: persistent disease or conversion to bullous pemphigoid? J Am Acad Dermatol 2003 49 : 302 7.
3. Fine J, Omura EF. Herpes gestationis: persistent disease activity 11 years post partum. Arch Dermatol 1985 109 : 131 9.
4. Jenkins RE, Vaughan Jones SA, Black MM. Conversion of pemphigoid gestationis to bullous pemphigoid: two refractory cases highlighting this association. Br J Dermatol 1996 135 : 595 8.
5. Holmes RC, Williamson DM, Black MM. Herpes gestationis persisting for 12 years post partum. Arch Dermatol 1986 122 : 375 6.
6. Kreuter A, Breuckmann F, Appelhans C et al. Intravenous immune globulin in the treatment of persistent pemphigoid gestationis. J Am Acad Dermatol 2004 51 : 1027 8.
7. Fatourechi MM, El-Azhary RA, Gibson LE. Rituximab: applications in dermatology. Int J Dermatol 2006 45 : 1143 55.
8. Espana A, Fernandez-Galar M, Lloret P et al. Long-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations. J Am Acad Dermatol 2004 50 : 974 6.
9. Cianchini G, Ruffelli M, Corona R et al. Rituximab in the treatment of severe pemphigus vulgaris: a report of five cases. J Invest Dermatol 2005 125 : 1089.